DGAP-News

MeVis Medical Solutions AG: MeVis publishes final figures for fiscal year 2013 / Shares in Medis sold in April 2014 - Seite 2

EUR 14.0 m at year-end (compared to EUR 8.7 m as at December 31, 2012). In
addition to the good operating performance, the reduction of receivables
has contributed significantly to this very strong cash flow of EUR 5.3 m.

"Over the past two years we already considerably simplified the structure
of MeVis. In order to focus on our industrial customers, our online
services as well as our core fields breast, lung and liver we have sold our
41% stake in the Dutch Medis Holding B.V. to the majority stake holder and
original owner the Reiber Consultancy B.V. in April." said Dr. Robert
Hannemann, CFO of MeVis Medical Solutions AG. "The proceeds from the sale
of our shares in the amount of EUR 0.5 m approximately equals the carrying
value of the investment, so that the divestment has largely no effect on
the net income."

"Following the early extension of the existing license agreement with
Hologic until end of 2015 we substantiate our discussions with Hologic
about the further cooperation and our future support in development. We
expect to achieve a contractual agreement on this within this quarter."
added Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. "The expansion
of the industrial customers segment through broadening of the product range
for our existing customers as well as through enhanced acquisition of new
customers is the essential focus of our activities. In addition to
expanding our clinical and technological expertise in breast diagnostic we
will increasingly put or focus on the development of a lung screening
solution. We see lung screening as the market with the highest growth
potential in the near future."

The interim financial statement for the first quarter 2014 will be
published on May 19, 2014.


End of Corporate News

---------------------------------------------------------------------

24.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
264281 24.04.2014